With our unparalleled history of expertise in processing OSDs, from pills and pellets to MUPS, and our tried and tested technologies, the GEA pharmaceutical test facilities supply added value to test, develop and optimize your products and processes with cutting-edge batch and continuous technologies.
From powder to coated tablet and from R&D to full-scale manufacturing, no other supplier offers such a wide range of batch technologies for oral solid dosage form production.
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products by focusing on quality during the whole product lifecycle — not just “tested in” quality — and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks
The innovations that GEA has developed include a unique technology that independently and simultaneously measures and controls both tablet weight and hardness, and a weight control system that provides increased sensitivity at lower forces.
Apart from our main test facilities in Wommelgem, Halle and Columbia, MD, GEA has collaborations with a number of universities and private research institutes to offer trial opportunities in other regions worldwide.
GEA recognizes the important role that training plays in the proper use of its equipment. Whether the need is theory, general operational instruction or specific process-related guidance, GEA is focused on helping you learn to use our technology to the fullest.
GEA からのニュースに登録することで、GEA の革新的な技術やストーリーに常にお知りいただけます。